Literature DB >> 26056022

Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II).

Hui Zheng1,2, Chong Shao1,2, Yan Zheng1,2,3, Jin-Wei He1,2, Wen-Zhen Fu1,2, Chun Wang1,2, Zhen-Lin Zhang4,5.   

Abstract

Autosomal dominant osteopetrosis type II (ADO-II) is a heritable bone disorder characterized by osteosclerosis, predominantly involving the spine (vertebral end-plate thickening, or rugger-jersey spine), the pelvis ("bone-within-bone" structures) and the skull base. Chloride channel 7 (CLCN7) has been reported to be the causative gene. In this study, we aimed to identify the pathogenic mutation in four Chinese families with ADO-II. All 25 exons of the CLCN7 gene, including the exon-intron boundaries, were amplified and sequenced directly in four probands from the Chinese families with ADO-II. The mutation site was then identified in other family members and 250 healthy controls. In family 1, a known missense mutation c.296A>G in exon 4 of CLCN7 was identified in the proband, resulting in a tyrosine (UAU) to cysteine (UGU) substitution at p.99 (Y99C); the mutation was also identified in his affected father. In family 2, a novel missense mutation c.865G>C in exon 10 was identified in the proband, resulting in a valine (GUC) to leucine (CUC) substitution at p.289 (V289L); the mutation was also identified in her healthy mother and sister. In family 3, a novel missense mutation c.1625C>T in exon 17 of CLCN7 was identified in the proband, resulting in an alanine (GCG) to valine (GUG) substitution at p.542 (A542V); the mutation was also identified in her father. In family 4, a hot spot, R767W (c.2299C>T, CGG>TGG), in exon 24 was found in the proband which once again proved the susceptibility of the site or the similar genetic background in different races. Moreover, two novel mutations, V289L and A542V, occurred at a highly conserved position, found by a comparison of the protein sequences from eight vertebrates, and were predicted to have a pathogenic effect by PolyPhen-2 software, which showed "probably damaging" with a score of approximately 1. These mutation sites were not identified in 250 healthy controls. Our present findings suggest that the novel missense mutations V289L and A542V in the CLCN7 gene were responsible for ADO-II in the two Chinese families.

Entities:  

Keywords:  Autosomal dominant osteopetrosis type II; CLCN7; Mutation

Mesh:

Substances:

Year:  2015        PMID: 26056022     DOI: 10.1007/s00774-015-0682-2

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  21 in total

Review 1.  DNA methylation in states of cell physiology and pathology.

Authors:  Anetta Sulewska; Wieslawa Niklinska; Miroslaw Kozlowski; Lukasz Minarowski; Wojciech Naumnik; Jacek Niklinski; Katarzyna Dabrowska; Lech Chyczewski
Journal:  Folia Histochem Cytobiol       Date:  2007       Impact factor: 1.698

2.  The virulence gene and clinical phenotypes of osteopetrosis in the Chinese population: six novel mutations of the CLCN7 gene in twelve osteopetrosis families.

Authors:  Chun Wang; Hao Zhang; Jin-Wei He; Jie-Mei Gu; Wei-Wei Hu; Yun-Qiu Hu; Miao Li; Yu-Juan Liu; Wen-Zhen Fu; Hua Yue; Yao-Hua Ke; Zhen-Lin Zhang
Journal:  J Bone Miner Metab       Date:  2011-09-28       Impact factor: 2.626

3.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

Review 4.  Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form.

Authors:  C C Johnston; N Lavy; T Lord; F Vellios; A D Merritt; W P Deiss
Journal:  Medicine (Baltimore)       Date:  1968-03       Impact factor: 1.889

5.  Intrafamilial phenotypic variability of osteopetrosis due to chloride channel 7 (CLCN7) mutations.

Authors:  Ana Belinda Campos-Xavier; Jean-Laurent Casanova; Yves Doumaz; Josué Feingold; Arnold Munnich; Valérie Cormier-Daire
Journal:  Am J Med Genet A       Date:  2005-03-01       Impact factor: 2.802

6.  Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations.

Authors:  Alessandra Pangrazio; Michael Pusch; Elena Caldana; Annalisa Frattini; Edoardo Lanino; Parag M Tamhankar; Shubha Phadke; Antonio Gonzalez Meneses Lopez; Paul Orchard; Ercan Mihci; Mario Abinun; Michael Wright; Kim Vettenranta; Ivo Bariae; Daniela Melis; Ilhan Tezcan; Clarisse Baumann; Franco Locatelli; Marco Zecca; Edwin Horwitz; Lamia Sfaihi Ben Mansour; Mirjam Van Roij; Paolo Vezzoni; Anna Villa; Cristina Sobacchi
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

7.  Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II).

Authors:  Zhen-Lin Zhang; Jin-Wei He; Hao Zhang; Wei-Wei Hu; Wen-Zhen Fu; Jie-Mei Gu; Jin-Bo Yu; Gao Gao; Yun-Qiu Hu; Miao Li; Yu-Juan Liu
Journal:  J Bone Miner Metab       Date:  2009-03-14       Impact factor: 2.626

8.  Predicting functional effect of human missense mutations using PolyPhen-2.

Authors:  Ivan Adzhubei; Daniel M Jordan; Shamil R Sunyaev
Journal:  Curr Protoc Hum Genet       Date:  2013-01

9.  Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis.

Authors:  Ana Belinda Campos-Xavier; Jorge M Saraiva; Letícia M Ribeiro; Arnold Munnich; Valérie Cormier-Daire
Journal:  Hum Genet       Date:  2002-11-07       Impact factor: 4.132

10.  Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations.

Authors:  C Letizia; A Taranta; S Migliaccio; C Caliumi; D Diacinti; E Delfini; E D'Erasmo; M Iacobini; M Roggini; O M E Albagha; S H Ralston; A Teti
Journal:  Calcif Tissue Int       Date:  2003-11-26       Impact factor: 4.333

View more
  8 in total

1.  Autosomal dominant osteopetrosis type II resulting from a de novo mutation in the CLCN7 gene: A case report.

Authors:  Xiu-Li Song; Li-Yuan Peng; Dao-Wen Wang; Hong Wang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

Review 2.  Genetics of Osteopetrosis.

Authors:  Eleonora Palagano; Ciro Menale; Cristina Sobacchi; Anna Villa
Journal:  Curr Osteoporos Rep       Date:  2018-02       Impact factor: 5.096

3.  Novel CLCN7 mutation identified in a Han Chinese family with autosomal dominant osteopetrosis-2.

Authors:  Hao Deng; Dan He; Pengfei Rong; Hongbo Xu; Lamei Yuan; Liu Li; Qian Lu; Yi Guo
Journal:  Mol Pain       Date:  2016-06-20       Impact factor: 3.395

4.  Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in CLCN7.

Authors:  Xiang Chen; Kun Zhang; Janet Hock; Chunyu Wang; Xijie Yu
Journal:  Bone Res       Date:  2016-11-29       Impact factor: 13.567

5.  Clinical and molecular characterization of five Chinese patients with autosomal recessive osteopetrosis.

Authors:  Huanhuan Liang; Niu Li; Ru-En Yao; Tingting Yu; Lixia Ding; Jing Chen; Jian Wang
Journal:  Mol Genet Genomic Med       Date:  2021-09-21       Impact factor: 2.183

Review 6.  The Role of the Lysosomal Cl-/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration.

Authors:  Giovanni Zifarelli
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

7.  Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study.

Authors:  Ziyuan Wang; Xiang Li; Ya Wang; Wenzhen Fu; Yujuan Liu; Zhenlin Zhang; Chun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-17       Impact factor: 5.555

8.  Genetic Analysis of CLCN7 in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.

Authors:  Seon Young Kim; Younghak Lee; Yea Eun Kang; Ji Min Kim; Kyong Hye Joung; Ju Hee Lee; Koon Soon Kim; Hyun Jin Kim; Bon Jeong Ku; Minho Shong; Hyon Seung Yi
Journal:  Endocrinol Metab (Seoul)       Date:  2018-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.